How GlobalFoundries’ (GFS) Dresden Expansion and Silicon Labs Deal Could Shape Its Manufacturing Future

GlobalFoundries Inc.

GlobalFoundries Inc.

GFS

0.00

  • In late October 2025, GlobalFoundries and Silicon Labs announced the expansion of their partnership to develop next-generation, energy-efficient wireless technologies, while GlobalFoundries also unveiled a plan to invest EUR 1.1 billion to significantly expand its Dresden, Germany wafer manufacturing site by 2028, supported by government incentives.
  • These moves reflect rising demand for secure, low-power IoT and wireless chips, and highlight GlobalFoundries’ efforts to strengthen supply chain resilience in both the US and Europe amid an evolving geopolitical landscape.
  • We'll examine how the Dresden expansion and Silicon Labs partnership may reshape GlobalFoundries’ global manufacturing and technology growth story.

These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

GlobalFoundries Investment Narrative Recap

To hold GlobalFoundries (GF) shares, investors generally need to believe in the company’s ability to benefit from robust demand in automotive, industrial, and communications semiconductors, despite its limited exposure to advanced process nodes. The expansion with Silicon Labs and the Dresden investment reinforce GF’s regional supply chain strategy but do not materially alter the key short-term catalyst, accelerating design wins in high-margin markets, or the principal risk, namely volatility from customer inventory patterns and ongoing pricing pressures.

Among recent announcements, the expanded partnership with Silicon Labs is particularly relevant. By advancing energy-efficient wireless chip development on its latest 40nm Ultra Low Power platform at its Malta, New York facility, GF aims to address growing IoT and industrial demand while strengthening U.S. supply chain resilience, directly supporting its core growth catalyst: scaling global manufacturing capacity to meet end-market needs.

However, investors should keep in mind that even as regional capacity increases, the risk of persistent pricing pressure in smart mobile and IoT chips remains an important factor...

GlobalFoundries' outlook anticipates $8.6 billion in revenue and $1.4 billion in earnings by 2028. This trajectory assumes an 8.0% annual revenue growth rate and a $1.515 billion increase in earnings from the current -$115.0 million.

Uncover how GlobalFoundries' forecasts yield a $39.43 fair value, a 11% upside to its current price.

Exploring Other Perspectives

GFS Community Fair Values as at Nov 2025
GFS Community Fair Values as at Nov 2025

Five fair value estimates from the Simply Wall St Community range from US$27.47 to US$54.14, highlighting significant differences in how investors assess GF’s revenue growth outlook. While many see upside in GF’s capacity expansions, ongoing pricing and margin risks in mobile and IoT segments could affect overall performance, so it’s worth exploring the full spectrum of community views.

Explore 5 other fair value estimates on GlobalFoundries - why the stock might be worth 23% less than the current price!

Build Your Own GlobalFoundries Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your GlobalFoundries research is our analysis highlighting 1 key reward that could impact your investment decision.
  • Our free GlobalFoundries research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate GlobalFoundries' overall financial health at a glance.

Looking For Alternative Opportunities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

  • Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
  • The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
  • AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.